(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SERAC BIOSCIENCES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SERAC BIOSCIENCES

ST13

US500000079401870

Class

1, 5, 42

Filing

79401870

Registration

7877097

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

04/03/2026

Trademark type

Word

Nice classes

1, 5, 42

Filing date

06/03/2024

Registration date

08/05/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/05/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

O'BRIEN, JENNIFER LYNN

Law office

N30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Serac Biosciences AG

Representatives

Michael J. Leonard Fox Rothschild LLP

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicals for use in industry and science; biological preparations for use in industry and science.

Class 5

Pharmaceuticalsmedical and veterinary preparationsnamely pharmaceutical and medical preparations for the treatment of cancerautoimmune diseases and inflammatory diseases

Class 42

Scientific and technological servicesnamely scientific researchanalysis and testing in the field of cancerautoimmune diseases and inflammatory diseases and product research and design relating thereto; Industrial analysis and industrial research in the field of cancerautoimmune diseases and inflammatory diseases and industrial design services

Publications

History of USPTO decisions and trademark events.

25 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/05/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/15/2026

FIMP

FINAL DISPOSITION PROCESSED

02/14/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/22/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/07/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

01/07/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/05/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/05/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/05/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/17/2025

PUBO

PUBLISHED FOR OPPOSITION

06/17/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/11/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/17/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/23/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/22/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/22/2025

RFNT

REFUSAL PROCESSED BY IB

01/25/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/03/2025

RFRR

REFUSAL PROCESSED BY MPU

01/03/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/17/2024

CNRT

NON-FINAL ACTION WRITTEN

12/16/2024

DOCK

ASSIGNED TO EXAMINER

12/14/2024

MAFR

APPLICATION FILING RECEIPT MAILED

08/21/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/09/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/08/2024

Continuous trademark protection

Get notified about every new filing that threatens SERAC BIOSCIENCES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.